Owc Pharmaceutical Research Stock Today
| OWCP Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 9
|
OWC Pharmaceutical is selling at 1.0E-4 as of the 31st of January 2025; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 1.0E-4. OWC Pharmaceutical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 1st of January 2025 and ending today, the 31st of January 2025. Click here to learn more.
OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Ramat Gan, Israel. Owc Pharmaceutical is traded on OTC Exchange in the United States.. The company has 497.5 M outstanding shares. More on OWC Pharmaceutical Research
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
OWC Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
OWC Pharmaceutical Research [OWCP] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 49.75 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OWC Pharmaceutical's market, we take the total number of its shares issued and multiply it by OWC Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. OWC Pharmaceutical conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 497.5 M outstanding shares.
OWC Pharmaceutical Research currently holds about 1.47 M in cash with (2.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check OWC Pharmaceutical Probability Of Bankruptcy
Ownership AllocationOWC Pharmaceutical secures a total of 497.5 Million outstanding shares. OWC Pharmaceutical owns 11.15 % of its outstanding shares held by insiders and 0.0 % owned by institutions. Please note that no matter how many assets the company retains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check OWC Ownership Details
OWC Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in OWC Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
OWC Pharmaceutical Corporate Management
| Ziv Turner | Chief Officer | Profile | |
| Pr Ramot | Consultant | Profile | |
| Oron DVM | Chief Officer | Profile | |
| Alon Sinai | Chief Officer | Profile | |
| Yehuda Baruch | Chief Science Officer | Profile |
Additional Tools for OWC Pink Sheet Analysis
When running OWC Pharmaceutical's price analysis, check to measure OWC Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OWC Pharmaceutical is operating at the current time. Most of OWC Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of OWC Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OWC Pharmaceutical's price. Additionally, you may evaluate how the addition of OWC Pharmaceutical to your portfolios can decrease your overall portfolio volatility.